Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: 2-Amino-N-(8-(o-chlorobenzyl)-3-beta-nortropanyl)-4-methoxy-5-pyrimidi necarboxamide
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang

84923-35-3

84923-35-3 structure

84923-35-3 structure

Name: 2-Amino-N-(8-(o-chlorobenzyl)-3-beta-nortropanyl)-4-methoxy-5-pyrimidi necarboxamide
Chemical Name: 2-amino-N-[8-[(2-chlorophenyl)methyl]-8-azabicyclo[3.2.1]octan-3-yl]-4-methoxypyrimidine-5-carboxamide
CAS Number: 84923-35-3
Molecular Formula: C₂₀H₂₄ClN₅O₂
Molecular Weight: 401.89000
Create Date: 2017-07-30 01:14:57
Modify Date: 2024-01-09 18:38:14

Name	2-amino-N-[8-[(2-chlorophenyl)methyl]-8-azabicyclo[3.2.1]octan-3-yl]-4-methoxypyrimidine-5-carboxamide

Density	1.36g/cm3
Molecular Formula	C₂₀H₂₄ClN₅O₂
Molecular Weight	401.89000
Exact Mass	401.16200
PSA	97.59000
LogP	3.08900
Index of Refraction	1.648

CHEMICAL IDENTIFICATION

RTECS NUMBER :: UV7701250

CHEMICAL NAME :: 5-Pyrimidinecarboxamide, 2-amino-N-(8-(o-chlorobenzyl)-3-beta-nortropanyl)-4-m ethoxy-

CAS REGISTRY NUMBER :: 84923-35-3

LAST UPDATED :: 199612

DATA ITEMS CITED :: 1

MOLECULAR FORMULA :: C20-H24-Cl-N5-O2

MOLECULAR WEIGHT :: 401.94

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 150 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: EJMCA5 European Journal of Medicinal Chemistry--Chimie Therapeutique. (Editions Scientifiques Elsevier, 29 rue Buffon, F-75005, Paris, France) V.9- 1974- Volume(issue)/page/year: 19,105,1984

611-19-8 structure

611-19-8

76352-25-5 structure

76352-25-5

~74%

84923-35-3 structure

84923-35-3

Literature: Dostert; Imbert; Langlois; et al. European Journal of Medicinal Chemistry, 1984 , vol. 19, # 2 p. 105 - 110

542-05-2 structure

542-05-2

~%

84923-35-3 structure

84923-35-3

Literature: Dostert; Imbert; Langlois; et al. European Journal of Medicinal Chemistry, 1984 , vol. 19, # 2 p. 105 - 110

532-24-1 structure

532-24-1

~%

84923-35-3 structure

84923-35-3

Literature: Dostert; Imbert; Langlois; et al. European Journal of Medicinal Chemistry, 1984 , vol. 19, # 2 p. 105 - 110

1515-26-0 structure

1515-26-0

~%

84923-35-3 structure

84923-35-3

Literature: Dostert; Imbert; Langlois; et al. European Journal of Medicinal Chemistry, 1984 , vol. 19, # 2 p. 105 - 110

76352-24-4 structure

76352-24-4

~%

84923-35-3 structure

84923-35-3

Literature: Dostert; Imbert; Langlois; et al. European Journal of Medicinal Chemistry, 1984 , vol. 19, # 2 p. 105 - 110

76272-36-1 structure

76272-36-1

~%

84923-35-3 structure

84923-35-3

Literature: Dostert; Imbert; Langlois; et al. European Journal of Medicinal Chemistry, 1984 , vol. 19, # 2 p. 105 - 110